April 9, 2021
Researchers at General Electric are set to begin research into how they can turn commonly-used surfaces into COVID-19-detecting devices, the company announced this week.
The GE Research team has received a 24-month grant from the National Institutes of Health to develop miniature sensors that can be embedded into mobile devices in order to detect COVID-19 particles on their surfaces.
“We all come...
Photo by Akili Interactive.
April 9, 2021
Akili Interactive, the maker of the FDA De Novo-authorized digital therapeutic EndeavorRx, will be testing its video game ADHD treatment as a potential treatment for cognitive impairments in COVID-19 survivors.
Through collaborations with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center, Akili will conduct two separate randomized, controlled clinical...
April 8, 2021
Origami is more traditionally associated with the art of paper folding, but one British startup is using the technique to develop a treatment for brain aneurysms.
Oxford Endovascular Ltd has raised $10 million in Series A funding for its OxiFlow solution, which aims to overcome challenges with existing medical devices.
Vulpes Investment Management led the round, with the Additio Investment Group...
April 2, 2021
The EU has approved an artificial intelligence (AI) technology that can identify people at risk of a fatal heart attack, years before it strikes.
The CaRi-Heart technology, developed by British Heart Foundation (BFH) spinout company Caristo Diagnostics, utilises coronary CT angiogram (CTTA) scans already performed in clinical practice.
It uses AI and deep-learning technology to produce a fat...
April 1, 2021
The United Arab Emirates (UAE) has become the first country in the Arab world to begin manufacturing a COVID-19 vaccine with a full production schedule underway.
Hayat-Vax, a joint collaboration between Sinopharm CNBG and Abu Dhabi’s G42, was announced earlier this week during the launch of a new purpose-built research and development hub for life sciences, biotechnology and vaccine production in...
March 31, 2021
An Abu Dhabi-based startup is claiming it has become the “first app in the world” to offer bookings for at-home COVID-19 vaccinations.
Rizek, which specialises in on-demand personal and home services – such as DIY, tutoring, and beauty and wellness – has added a feature that enables anyone, subject to their location in the United Arab Emirates (UAE), to book a private COVID-19 vaccine to be...
(Photo by Sundry Photography/Getty Images)
March 29, 2021
On Thursday, Amazon landed an FDA Emergency Use Authorization for its COVID-19 test kit with at-home sample collection.
According to FDA documents, the product is cleared for self-sample collection by nasal swab for individuals aged 18 years and over. The kit can be used either under the supervision of a healthcare provider or unsupervised at home. The kit includes a nasal swab, a collection tube...
March 26, 2021
In Germany, the public health insurers are in charge of the ePatient record (ePA) app delivery. MobiHealthNews asked Sandra Hoyer, ePA project manager at one of Germany’s main insurers, Techniker Krankenkasse (TK), how the implementation works - and how it has been used so far.
Q. The payers are responsible for providing the national ePA in Germany. How does that work?
At the moment we provide...
March 24, 2021
Everlywell, a leader in the at-home diagnostic testing space, has acquired PWNHealth and its subsidiary Home Access Health to form a new parent company called Everly Health.
PWNHealth and Home Access Health both have self-collected lab test services, and by combining the companies, Everly Health will support more than 20 million people annually in all 50 U.S. states, Canada and Puerto Rico,...
(Photo by MR.Cole_Photographer/Getty Images)
March 23, 2021
UK biotech firm Genomics plc is working with the NHS on a pilot study using genetic information to predict patients’ risk of heart disease.
Around 1,000 people in north-east England who attend routine GP health checks, will take part in the trial.
An integrated risk tool (IRT), created by Oxford University spin-off Genomics plc, will be used to estimate each patient's risk of developing...